Hydrogel: a new material for intravesical drug delivery after bladder cancer surgery
- 14 February 2024
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 12 (12) , 2938-2949
Abstract
The standard treatment for non-muscle invasive bladder cancer (NMIBC) is transurethral resection of bladder tumor (TURBT).Keywords
Funding Information
- National Natural Science Foundation of China (82202312)
This publication has 84 references indexed in Scilit:
- Recent advances in three-dimensional bioprinted nanocellulose-based hydrogel scaffolds for biomedical applicationsKorean Journal of Chemical Engineering, 2021
- Cancer statistics for the year 2020: An overviewInternational Journal of Cancer, 2021
- Voiding Dysfunction After Neobladder Urinary DiversionCurrent Bladder Dysfunction Reports, 2020
- Mucoadhesive Cationic Polypeptide Nanogel with Enhanced Penetration for Efficient Intravesical Chemotherapy of Bladder CancerAdvanced Science, 2018
- Design and evaluation of chitosan-β-cyclodextrin based thermosensitive hydrogelBiochemical Engineering Journal, 2016
- Review: Application of Nanoparticles in Urothelial Cancer of the Urinary BladderJournal of Medical and Biological Engineering, 2015
- A Review on Chitin and Chitosan Polymers: Structure, Chemistry, Solubility, Derivatives, and ApplicationsChemBioEng Reviews, 2015
- A Floating Hydrogel System Capable of Generating CO2 Bubbles to Diminish Urinary Obstruction After Intravesical InstillationPharmaceutical Research, 2014
- In Situ Floating Hydrogel for Intravesical Delivery of Adriamycin Without Blocking Urinary TractJournal of Pharmaceutical Sciences, 2014
- A magnetic chitosan hydrogel for sustained and prolonged delivery of Bacillus Calmette–Guérin in the treatment of bladder cancerBiomaterials, 2013